These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients. Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608 [TBL] [Abstract][Full Text] [Related]
6. Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma. Bu L; Hameed NUF; Luo C; Hong P; Zhou X; Wang S; Wu S J Neurooncol; 2021 Mar; 152(1):27-36. PubMed ID: 33486679 [TBL] [Abstract][Full Text] [Related]
7. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Oncotarget; ; . PubMed ID: 27626492 [TBL] [Abstract][Full Text] [Related]